国际眼科纵览 ›› 2023, Vol. 47 ›› Issue (1): 62-67.doi: 10.3760/ cma.j.issn.1673-5803.2023.01.012

• 综述 • 上一篇    下一篇

辅助T细胞17在干眼症发病机制中的作用

沙咏怡 孔雪晴 项敏泓   

  1. 上海中医药大学附属普陀医院眼科 200062
  • 收稿日期:2022-09-14 出版日期:2023-02-22 发布日期:2023-03-11
  • 通讯作者: 项敏泓,Email: xiangminhong@sohu.com E-mail:xiangminhong@sohu.com
  • 基金资助:
    国家自然科学基金(82074495);上海中医药大学预算内项目(2020LK068);上海市普陀区中心医院匠才计划(2022-RCJC-06)

Roles of Th17 cells in pathogenesis of dry eye disease

Sha Yongyi, Kong Xueqing, Xiang Minhong   

  1. Department of Ophthalmology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China
  • Received:2022-09-14 Online:2023-02-22 Published:2023-03-11
  • Contact: Xiang Minhong, Email: xiangminhong@sohu.com E-mail:xiangminhong@sohu.com
  • Supported by:
    National Natural Science Foundation of China (82074495); Budget Project of Shanghai University of Traditional Chinese Medicine (2020LK068); Shanghai Putuo District Central Hospital Craftsman Plan (2022-RCJC-06)

摘要: 干眼症是临床常见的眼表疾病,患者出现明显的免疫稳态破坏。辅助T细胞亚群中产生白介素-17 (interleukin-17,IL-17) 的辅助T细胞17(T helper type 17 cells,Th17)作为重要的免疫细胞广泛存在于人体中,产生标志性的细胞因子如IL-17A、IL-17F和IL-22。转化生长因子-β、IL-6、IL-21和IL-23等可促进Th17细胞的分化。Th17细胞在干眼症的免疫反应中起着尤为重要的作用,干眼症中Th17细胞相关细胞因子表达增高,Th17/调节性T细胞(regulatory T cell,Treg)比例上调,Th17细胞迁移至眼表可进一步导致干眼症的发生、发展。因此,寻求Th17细胞相关的治疗靶点可能是治疗干眼症的关键因素。(国际眼科纵览,2023, 47:62-67)

关键词: Th17, 白介素, 干眼, 自身免疫性疾病

Abstract: Dry eye is a common ocular surface disease in clinic, and patients show obvious immune homeostasis disruption. Th17 cells, one of the Th subtypes and producing interleukin-17 (IL-17), are widely present in the human body as important immune cells. They generate the iconic cytokines IL-17A, IL-17F, and IL-22. Transforming growth factor-β, IL-6, IL-21, and IL-23 can promote the differentiation of Th17 cells. Th17 cells play a particularly important role in the immune response of dry eye disease. In dry eye disease, the expression of Th17 related cytokines is increased, and the proportion of Th17/regulatory T cell (Treg) is increased. The migration of Th17 to the ocular surface can further lead to the occurrence and development of dry eye disease. Therefore, searching for Th17-related therapeutic targets may be a key factor in the treatment of dry eye. (Int Rev Ophthalmol, 2023, 47: 62-67)

Key words: Th17, interleukin, dry eye disease, autoimmune disease